Ignite Creation Date:
2024-05-05 @ 9:20 PM
Last Modification Date:
2024-10-26 @ 10:02 AM
Study NCT ID:
NCT00863174
Status:
COMPLETED
Last Update Posted:
2019-05-03
First Post:
2009-03-16
Brief Title:
A Bioequivalence Study of SPARC_147709 in Patients With Multiple Myeloma
Sponsor:
Sun Pharma Advanced Research Company Limited
Organization:
Sun Pharma Advanced Research Company Limited
Study Overview
Official Title:
A Randomized Open Label Two Treatment Two Period Two Sequence Single Dose Crossover Bioequivalence Study of SPARC_147709- Test and Reference 2mgml 30 mgm2 Dose in Patients With Multiple Myeloma
Status:
COMPLETED
Status Verified Date:
2019-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Safety and bioequivalence of SPARC_147709
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None